The emerging treatment of tirzepatide peptide represents a significant advance in the management of the condition. Distinct from existing therapies, tirzepatide impacts two pathways – glucagon-like peptide-1 (GLP-1) and GIP – providing greater glucose control and possible weight reduction. Expert